4,800 patients accounted for $2.1B in drug spend last year, study finds

(By Maia Anderson for Becker’s Hospital Review)

The number of patients who need costly specialty drugs is sharply increasing, according to a recent study by Prime Therapeutics.

Specialty drugs that treat complex conditions, such as cancer, can cost between $500,000 and $2 million. These drugs now make up more than 50 percent of total drug spending, according to Prime. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.